NCT06200870View on ClinicalTrials.gov

ID as a Promoter of IH-induced CAVD

Not yet recruitingOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions

Iron DeficienciesCalcified Aortic Valve

All Listed Sponsors

lead

Qilu Hospital of Shandong University

OTHER

NCT06200870 - ID as a Promoter of IH-induced CAVD | Biotech Hunter | Biotech Hunter